IL-2-induced proliferative response is controlled by loci Cinda1 and Cinda2 on mouse chromosomes 11 and 12: A distinct control of the response induced by different IL-2 concentrations

Genomics

Volumn 42, Issue 1, 1997, Pages 11-15

  Krulová, Magdaléna ^a   Havelková, Helena ^a   Kosařová, Marcela ^a   Holáň, Vladimír ^a   Hart, Augustinus A M ^b   Demant, Peter ^b   Lipoldová, Marie ^a  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CENTROMERE; CHROMOSOME 11; CHROMOSOME 12; DISEASE PREDISPOSITION; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC REGULATION; GENOTYPE; HEREDITY; HYBRIDIZATION; INBREEDING; INFECTION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SPLEEN CELL; STRAIN DIFFERENCE; T LYMPHOCYTE;

ANIMALIA;

EID: 0031570340     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1997.4694     Document Type: Article

References (35)

1. Allison, J. P. (1994). CD28-B7 interaction in T-cell activation. Curr. Opin. Immunol. 6: 414-419.
2. Beadling, C., Johnson, K. W., and Smith, K. A. (1993). Isolation of interleukin 2 induced immediate-early genes. Proc. Natl. Acad. Sci. USA 90: 2719-2723.
3. Calland, R., and Gearing, A. (1994). IL-2. In "The Cytokine Fact Book," p. 42, Academic Press, London.
4. Demant, P. (1992). Genetic resolution of susceptibility to cancer -New perspectives. Semin. Cancer Biol. 3: 159-166.
5. Demant, P., and Hart, A. A. M. (1986). Recombinant congenic strains: A new tool for analyzing genetic traits determined by more than one gene. Immunogenetics 24: 416-422.
6. Demant, P., Lipoldová, M., and Svobodová, M. (1996). Resistance to Leishmania major in mice. Science 274: 1392. [Technical comment]
7. Dietrich, W., Katz, H., Lincoln, S. E., Shin, H.-S., Friedman, J., Dracopoli, N. C., and Lander, E. S. (1992). A genetic map of the mouse suitable for typing interspecific crosses. Genetics 131: 423-447.
8. Fijneman, R. J. A., Ophoff, R. A., Hart, A. A. M., and Demant, P. (1994). Kras-2 alleles, mutations, and lung tumor susceptibility in the mouse - An evaluation. Oncogene 9: 1417-1421.
9. Fijneman, R. J. A., de Vries, S. S., Jansen, R. C., and Demant, P. (1996). Complex interaction of new quantitative trait loci, Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nature Genet. 14: 465-467.
10. Friedmann, M. C., Migone, T.-S., Russell, S. M., and Leonard, W. J. (1996). Different interleukin 2 receptor β-chain tyrosines couple to at least two signalling pathways and synergistically mediate interleukin 2-induced proliferation. Proc. Natl. Acad. Sci. USA 93: 2077-2082.
11. Gorham, J. D., Güler, M. L., Steen, R. G., Mackey, A. J., Daly, M. J., Frederick, K., Dietrich, W. F., and Murphy, K. M. (1996). Genetic mapping of murine locus controlling development of T helper 1/T helper 2 type responses. Proc. Natl. Acad. Sci. USA 93: 12467-12472.
12. Groot, P. C., Moen, C. J. A., Dietrich, W., Sloye, J. P., Lander, E. S., and Demant, P. (1992). The recombinant congenic strains for analysis of multigenic traits: Genetic composition. FASEB J. 6: 2826-2835.
13. H1 cell development. Science 271: 984-987.
14. Havelková, H., Krulová, M., Kosařová, M., Holáň, V., Hart, A. A. M., Demant, P., and Lipoldová, M. (1996). Genetic control of T-cell proliferative response in mice linked to chromosomes 11 and 15. Immunogenetics 44: 475-477.
15. Herzberg, V. L., and Smith, K. A. (1987). T cell growth without serum. J. Immunol. 139: 998-1004.
16. Holáň, V., Lipoldová, M., and Demant, P. (1996). Identical genetic control of MLC reactivity to different MHC incompatibilities, independent of production of and response to IL-2. Immunogenetics 44: 27-35.
17. Karasuyama, H., and Melchers, F. (1988). Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4, or 5, using modified cDNA expression vectors. Eur. J. Immunol. 18: 97-104.
18. Kozak, C. A., and Leonard, W. J. (1995). Genetic mapping of the interleukin 2 receptor alpha and beta chain genes in the mouse. Mamm. Genome 6: 823-825.
19. Laird, P., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., and Berns, A. (1991). Simplified mammalian DNA isolation procedure. Nucleic Acids Res. 19: 4293.
20. Lander, E. S., and Schork, N. J. (1994). Genetic dissection of complex traits. Science 265: 2037-2048.
21. Lee, G. H., Benett, L. M., Carabeo, R. A., and Drinkwater, N. R. (1995). Identification of hepatocarcinogen resistance genes in DBA/ 2 mice. Genetics 193: 387-395.
22. Lipoldová, M., Kosařová, M., Zajícová, A., Holáň, V., Hart, A. A. M., Krulová, M., and Demant, P. (1995). Separation of multiple genes controlling the T-cell proliferative response to IL-2 and anti-CD3 using recombinant congenic strains. Immunogenetics 41: 301-311.
23. Matesanz, F., Alcina, A., and Pellicer, A. (1993). Existence of at least five interleukin-2 molecules in different mouse strains. Immunogenetics 38: 300-303.
24. Minami, Y., Kono, T., Miyazaki, T., and Tanigushi, T. (1993). The IL-2 receptor complex: Its structure, function, and target genes. Annu. Rev. Immunol. 11: 245-267.
25. Miyazaki, T., Liu, Z.-J., Kawahara, A., Minami, Y., Yamada, K., Tsujimoto, Y., Barsoumian, E. L., Perlmutter, R. M., and Taniguichi, T. (1995). Three distinct IL-2 signalling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 81: 223-231.
26. Moen, C. J. A., van der Valk, M. A., Snoek, M., van Zutphen, L. F. M., von Deimling, O., and Demant, P. (1991). The recombinant congenic strains: A novel genetic tool applied to the study of colon tumor development in the mouse. Mamm. Genome 1: 217-227.
27. Moen, C. J. A., Snoek, M., Hart, A. A. M., and Demant, P. (1992). Scc-1, a novel colon cancer susceptibility gene in the mouse: Linkage to CD44 (Ly-24, Pgp-1) on chromosome 2. Oncogene 7: 563-566.
28. Moen, C. J. A., Groot, P. C., Hart, A. A. M., Snoek, M., and Demant, P. (1996). Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer. Proc. Natl. Acad. Sci. USA 93: 1082-1086.
29. Mori, N., Okumoto, M., Hart, A. A. M., and Demant, P. (1995). Apoptosis susceptibility gene mapped on chromosome 9 (Rapop2) and chromosome 3 (Rapop3). Genomics 30: 553-557.
30. Pardoll, D. M. (1995). Paracrine cytokine adjuvants in cancer immunotherapy. Annu. Rev. Immunol. 13: 399-415.
31. SAS/STAT User's Guide. (1989). Version 6, 4th ed., Vol. 2, pp. 936, 958-959, SAS Institute Inc., Cary, NC.
32. Stassen, A. P. M., Groot, P. C., Epping, J. T., and Demant, P. (1996). Genetic composition of the recombinant congenic strains. Mamm. Genome 7: 55-58.
33. Taneja, S. S., Pierce, W., Figlin, R., and Belldegrun, A. (1995). Immunotherapy for renal cell carcinoma: The era of interleukin-2 based treatment. Urology 45: 911-924.
34. Tanigushi, T. (1995). Cytokine signalling through nonreceptor protein tyrosine kinases. Science 268: 251-255.
35. van Wezel, T., Stassen, A. P. M., Moen, C. J. A., Hart, A. A. M., van der Valk, M. A., and Demant, P. (1996). Gene interaction and single gene effects in colon tumour susceptibility in mice. Nature Genet. 14: 468-470.